Qualitas Health has landed US$10 million in venture funds at a US$73 million post-money valuation. The algae specialist offers omega-3 products via its Iwi brand and is now set to commercialize plant-based protein by 2022 with the funding.
January 15, 2021
This clipping was added via the Protein Report NewsEngine, a market intelligence tool for tracking developments in the protein industries. Learn more.
